BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 32808250)

  • 1. Comparative Effectiveness of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors in Older Nursing Home Residents After Myocardial Infarction: A Retrospective Cohort Study.
    Zullo AR; Riester MR; Erqou S; Wu WC; Rudolph JL; Steinman MA
    Drugs Aging; 2020 Oct; 37(10):755-766. PubMed ID: 32808250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction.
    Fang G; Annis IE; Farley JF; Mahendraratnam N; Hickson RP; Stürmer T; Robinson JG
    Pharmacotherapy; 2018 Jan; 38(1):29-41. PubMed ID: 29059475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of renin angiotensin system inhibitor on 3-year clinical outcomes in acute myocardial infarction patients with preserved left ventricular systolic function: a prospective cohort study from Korea Acute Myocardial Infarction Registry (KAMIR).
    Kim KH; Choi BG; Rha SW; Choi CU; Jeong MH;
    BMC Cardiovasc Disord; 2021 May; 21(1):251. PubMed ID: 34020593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effectiveness of angiotensin receptor blockers vs. angiotensin-converting enzyme inhibitors on cardiovascular outcomes in patients initiating peritoneal dialysis.
    Shen JI; Saxena AB; Montez-Rath ME; Leng L; Chang TI; Winkelmayer WC
    J Nephrol; 2017 Apr; 30(2):281-288. PubMed ID: 27485007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin Receptor Blockers as an Alternative to Angiotensin-Converting Enzyme Inhibitors in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
    Lim S; Choo EH; Choi IJ; Ihm SH; Kim HY; Ahn Y; Chang K; Jeong MH; Seung KB
    J Korean Med Sci; 2019 Nov; 34(45):e289. PubMed ID: 31760711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II type 1 receptor blockers as a first choice in patients with acute myocardial infarction.
    Lee JH; Bae MH; Yang DH; Park HS; Cho Y; Lee WK; Jeong MH; Kim YJ; Cho MC; Kim CJ; Chae SC;
    Korean J Intern Med; 2016 Mar; 31(2):267-76. PubMed ID: 26701233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Effectiveness of Combination Therapy with Statins and Angiotensin-Converting Enzyme Inhibitors versus Angiotensin II Receptor Blockers in Patients with Coronary Heart Disease: A Nationwide Population-Based Cohort Study in Korea.
    Lee J; Lee S
    Pharmacotherapy; 2018 Nov; 38(11):1095-1105. PubMed ID: 30225928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Effectiveness of Angiotensin II Receptor Blockers Versus Angiotensin-Converting Enzyme Inhibitors Following Contemporary Treatments in Patients with Acute Myocardial Infarction: Results from the Korean Working Group in Myocardial Infarction (KorMI) Registry.
    Song PS; Seol SH; Seo GW; Kim DK; Kim KH; Yang JH; Hahn JY; Gwon HC; Ahn Y; Jeong MH; Song YB; Kim DI;
    Am J Cardiovasc Drugs; 2015 Dec; 15(6):439-49. PubMed ID: 26153396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Secondary Prevention Medication Use and Outcomes in Frail Older Adults After Acute Myocardial Infarction.
    Zullo AR; Mogul A; Corsi K; Shah NR; Lee SJ; Rudolph JL; Wu WC; Dapaah-Afriyie R; Berard-Collins C; Steinman MA
    Circ Cardiovasc Qual Outcomes; 2019 Apr; 12(4):e004942. PubMed ID: 31002274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of β-Blockers With Functional Outcomes, Death, and Rehospitalization in Older Nursing Home Residents After Acute Myocardial Infarction.
    Steinman MA; Zullo AR; Lee Y; Daiello LA; Boscardin WJ; Dore DD; Gan S; Fung K; Lee SJ; Komaiko KD; Mor V
    JAMA Intern Med; 2017 Feb; 177(2):254-262. PubMed ID: 27942713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renin-Angiotensin Inhibition and Outcomes in Nursing Home Residents With Heart Failure.
    Arundel C; Sheriff HM; Lam PH; Mohammed SF; Jones LG; Jurgens CY; Morgan CJ; Faselis C; Allman RM; Fonarow GC; Ahmed A
    Am J Ther; 2020; 27(3):e235-e242. PubMed ID: 30299270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on major adverse cardiac events in patients with newly diagnosed type 2 diabetes: a nationwide study.
    Shih CJ; Chu H; Ou SM; Chen YT
    Int J Cardiol; 2015 Nov; 199():283-9. PubMed ID: 26218587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme inhibitor/angiotensin receptor blocker use and cardiovascular outcomes in patients initiating peritoneal dialysis.
    Shen JI; Saxena AB; Montez-Rath ME; Chang TI; Winkelmayer WC
    Nephrol Dial Transplant; 2017 May; 32(5):862-869. PubMed ID: 27190342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and Suicide.
    Mamdani M; Gomes T; Greaves S; Manji S; Juurlink DN; Tadrous M; Kennedy SH; Antoniou T
    JAMA Netw Open; 2019 Oct; 2(10):e1913304. PubMed ID: 31617924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
    Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
    Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Statins for Secondary Prevention on Functioning and Other Outcomes Among Nursing Home Residents.
    Zullo AR; Ofori-Asenso R; Wood M; Zuern A; Lee Y; Wu WC; Rudolph JL; Liew D; Steinman MA
    J Am Med Dir Assoc; 2020 Apr; 21(4):500-507.e8. PubMed ID: 32144051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Myocardial Infarction Patients With Renal Dysfunction.
    Evans M; Carrero JJ; Szummer K; Åkerblom A; Edfors R; Spaak J; Jacobson SH; Andell P; Lindhagen L; Jernberg T
    J Am Coll Cardiol; 2016 Apr; 67(14):1687-97. PubMed ID: 27056774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EVALUATING THE PRESCRIPTION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS OR RECEPTOR BLOCKERS IN PATIENTS WITH DIABETES IN JORDAN.
    Mayyas F; Bataineh W; Jarab A
    Endocr Pract; 2017 Nov; 23(11):1289-1296. PubMed ID: 28816537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effects of ARBs, ACEis, and Statins on Clinical Outcomes of COVID-19 Infection Among Nursing Home Residents.
    De Spiegeleer A; Bronselaer A; Teo JT; Byttebier G; De Tré G; Belmans L; Dobson R; Wynendaele E; Van De Wiele C; Vandaele F; Van Dijck D; Bean D; Fedson D; De Spiegeleer B
    J Am Med Dir Assoc; 2020 Jul; 21(7):909-914.e2. PubMed ID: 32674818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary Prevention Medication Use After Myocardial Infarction in U.S. Nursing Home Residents.
    Zullo AR; Sharmin S; Lee Y; Daiello LA; Shah NR; John Boscardin W; Dore DD; Lee SJ; Steinman MA
    J Am Geriatr Soc; 2017 Nov; 65(11):2397-2404. PubMed ID: 29044457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.